Document Detail

A clinical-severity staging system for patients with lung cancer.
MedLine Citation:
PMID:  2299974     Owner:  NLM     Status:  MEDLINE    
The prognostic staging of cancer in general, and lung cancer in particular, has customarily depended mainly on morphologic distinctions. The gross anatomic extensiveness of cancers is cited with TNM stages that describe the primary tumor (T), spread to regional lymph nodes (N), and metastatic dissemination (M) to distant sites. Microscopic characteristics are cited according to the cancer's cell type (e.g., adenocarcinoma, epidermoid carcinoma) and/or grade of differentiation (e.g., well differentiated, poorly differentiated, anaplastic). Although the clinical manifestations, functional effects, and associated co-morbidity of a cancer are universally recognized as having major prognostic importance, they have not been classified with a standard system of taxonomy. When considered at all, clinical phenomena have been cited with a surrogate index of "performance status" that ignores the underlying clinical dysfunctions while being greatly affected by non-clinical phenomena, such as the patient's psychic status, economic motivations, and system of social support. The current research was done to develop a standard system of taxonomy (or "staging") for the prognostic impact of clinical distinctions in patients with primary lung cancer. Appropriate data were obtained, computer-coded, and analyzed from medical records for the complete clinical course of an inception cohort of 1266 patients who were first treated at either the Yale-New Haven Hospital or the West Haven Veterans Administration Hospital during the interval January 1, 1953-December 31, 1964. The information under analysis included clinical phenomena as well as anatomic extensiveness (TNM stage), microscopic histology, the chronometric duration of the interval from the first symptom of lung cancer to zero time, the iatrotropic reason why the patient sought medical attention, the presence of anemia, the amount of customary cigarette use, and the conventional demographic data for age and gender. The main clinical phenomena were expressed in variables for symptom pattern severity, and co-morbidity. Symptom pattern referred to the existence of specific pulmonic symptoms (e.g., hemoptysis), systemic symptoms (e.g., complaint of weight loss), and metastatic symptoms that might be mediastinal (e.g., superior vena cava syndrome), regional (e.g., the Horner syndrome), or distantly metastatic (e.g., central nervous system). The symptom severity variable included the amount of weight loss, and the existence of severe dyspnea or particularly severe tumor effects (such as mental obtundation, rather than hemiparesis in patients with CNS metastasis). Prognostic co-morbidity was cited for coexisting diseases, such as recurrent myocardial infarctions, that might be more lethal than the lung cancer itself.(ABSTRACT TRUNCATED AT 400 WORDS)
A R Feinstein; C K Wells
Related Documents :
25444904 - Targeted anticancer effect through microrna-181a regulated tumor-specific htert replace...
14984484 - A revised staging system for breast cancer.
25348584 - How risky is it to use e-cigarettes? smokers' beliefs about their health risks from usi...
25381064 - T-cell-associated cellular immunotherapy for lung cancer.
9436044 - In vitro effects of recombinant human granulocyte-macrophage colony-stimulating factor ...
18787354 - Complete remission in a colon cancer patient with a large, irresectable liver metastasi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Medicine     Volume:  69     ISSN:  0025-7974     ISO Abbreviation:  Medicine (Baltimore)     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-03-01     Completed Date:  1990-03-01     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2985248R     Medline TA:  Medicine (Baltimore)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1-33     Citation Subset:  AIM; IM    
Clinical Epidemiology Unit, Yale University, New Haven, Connecticut 06510.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Lung Diseases / classification,  mortality,  pathology*
Neoplasm Staging / methods*
Grant Support
13977-03-68-06//PHS HHS; HS00408/HS/AHRQ HHS; HS02764/HS/AHRQ HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Opioid-dependent growth of glial cultures: suppression of astrocyte DNA synthesis by met-enkephalin.
Next Document:  Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986.